根据韩国主要肝脏疾病的严重程度估算效用权重
Estimation of utility weights for major liver diseases according to disease severity in Korea.
作者信息
Ock Minsu, Lim So Yun, Lee Hyeon-Jeong, Kim Seon-Ha, Jo Min-Woo
机构信息
Department of Preventive Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
Asan Medical Center, Seoul, South Korea.
出版信息
BMC Gastroenterol. 2017 Sep 5;17(1):103. doi: 10.1186/s12876-017-0660-3.
BACKGROUND
The global burden of liver diseases, such as hepatocellular carcinoma and liver cirrhosis, is substantial. In this study, we estimated utility weights of liver disease-related health states in the general population using a visual analogue scale (VAS) and the standard gamble (SG) method.
METHODS
Depictions of standardized health states related to major liver diseases were developed based on patient education materials and previous publications. To fully reflect disease progression from diagnosis to prognosis, each health state comprised four parts: diagnosis, symptoms, treatment, and progression and prognosis. A total of 407 participants from the Korean general population evaluated the health states using the VAS and SG methods in computer-assisted personal interviews. After excluding illogical responses, mean utility weights were calculated for each health state.
RESULTS
The utility weights for health states were significantly different according to the existence of inconsistency in general. According to the VAS results, the health state with the highest utility was 'Chronic hepatitis B virus infection' (0.64), whereas the health state with the lowest utility was 'Hepatocellular carcinoma that requires palliative therapy' (0.17). Similarly, the SG results revealed that the health state with the highest utility was 'Chronic hepatitis B virus infection' (0.85), and the health state with the lowest utility was 'Hepatocellular carcinoma that requires palliative therapy' (0.40).
CONCLUSIONS
The estimated utility weights in this study will be useful to measure the burden of liver diseases and evaluate cost-utility of programs for reducing the burden of liver diseases.
背景
诸如肝细胞癌和肝硬化等肝脏疾病的全球负担十分沉重。在本研究中,我们使用视觉模拟量表(VAS)和标准博弈(SG)方法估算了普通人群中肝脏疾病相关健康状态的效用权重。
方法
基于患者教育材料和先前的出版物,开发了与主要肝脏疾病相关的标准化健康状态描述。为了充分反映从诊断到预后的疾病进展,每个健康状态包括四个部分:诊断、症状、治疗以及进展和预后。来自韩国普通人群的407名参与者在计算机辅助个人访谈中使用VAS和SG方法对健康状态进行了评估。在排除不合理的回答后,计算了每个健康状态的平均效用权重。
结果
总体而言,根据是否存在不一致情况,各健康状态的效用权重存在显著差异。根据VAS结果,效用最高的健康状态是“慢性乙型肝炎病毒感染”(0.64),而效用最低的健康状态是“需要姑息治疗的肝细胞癌”(0.17)。同样,SG结果显示,效用最高的健康状态是“慢性乙型肝炎病毒感染”(0.85),效用最低的健康状态是“需要姑息治疗的肝细胞癌”(0.40)。
结论
本研究中估算的效用权重将有助于衡量肝脏疾病的负担,并评估减轻肝脏疾病负担项目的成本效用。